The National Institutes of Health has launched a $37 million, five-year consortium to address the high stillbirth rate in the U.S. This initiative brings together four clinical sites and a data coordinating center across the country. The consortium aims to research and prevent stillbirths, which occur in over 20,000 U.S. births annually. Up to 25% of these losses may be preventable, with nearly half preventable for full-term pregnancies. Research targets include placental issues, fetal growth, reduced fetal movement, optimal delivery timing, and predictive technologies like AI and biomarkers. The project emphasizes collaboration with the stillbirth community and improving data standardization. This effort follows a national shift in acknowledging stillbirth as a significant public health concern, partly spurred by investigative journalism. Congressional action, including the SHINE for Autumn Act, also supports this increased focus. Experts are optimistic about reducing stillbirth rates to align with other wealthy nations. This is the NIH's most significant stillbirth-specific initiative in over a decade, offering hope for preventing this "preventable tragedy."